Our Commitment

Our Commitment

Akcea strives not only to be an advocate for patients living with serious and rare diseases, but also to be a partner to the health care professionals who care for these patients. At Akcea, we believe our therapies have potential to address the unmet needs and complex medical challenges of patients with these important, but less well understood disorders.

IONIS

Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For continued news and information about Akcea Therapeutics, please visit ionispharma.com. You are being redirected, please wait. If you have not been redirected in 30 seconds, please click the button below.

Go to ionispharma.com